FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Veterinary parasitology2002; 103(4); 277-297; doi: 10.1016/s0304-4017(01)00615-x

International harmonisation of anthelmintic efficacy guidelines (Part 2).

Abstract: The "International Co-operation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH)" is an international programme of co-operation between regulatory authorities and the animal health industries of the European Union, Japan and the United States of America which aims to harmonise the technical requirements for the registration of veterinary medicinal products. Australia and New Zealand participate as active observers. The objective of this second paper is to present additional guidelines established by the Working Group on anthelmintic guidelines: (1) efficacy of anthelmintics: specific recommendations for equine (VICH GL15), (2) efficacy of anthelmintics: specific recommendations for porcine (VICH GL16), (3) efficacy of anthelmintics: specific recommendations for canine (VICH GL19), (4) efficacy of anthelmintics: specific recommendations for feline (VICH GL20) and (5) efficacy of anthelmintics: specific recommendations for poultry (VICH GL21). These guidelines do not consist of rigid stipulations, but make clear recommendations on the minimal standards needed. To the veterinary profession, livestock producers and animal owners, harmonisation should mean quicker access to safer and more effective veterinary anthelmintics. In general, products should be relatively more affordable because of the reduction in registration costs and efficient use of resources by the regulatory authorities.
Get Full Text
Publication Date: 2002-01-05 PubMed ID: 11777607DOI: 10.1016/s0304-4017(01)00615-xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Guideline
  • Journal Article
  • Practice Guideline

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the formation of additional internationally harmonised guidelines regarding the effectiveness of anthelmintics (anti-parasitic drugs) in various animals by the Working Group of the International Cooperation on Harmonisation of Technical Requirements for the Registration of Veterinary Medicinal Products (VICH). The harmonisation aims to facilitate quicker access to safer, efficient, and affordable anthelmintic drugs by reducing registration costs and efficient resource use.

About the VICH and its objective

  • The research article focuses on the “International Co-operation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH)”. This international group consists of regulatory authorities and animal health industries from the European Union, Japan, and the United States. Australia and New Zealand also participate as active observers.
  • The primary aim of VICH is to harmonise the technical requirements for the registration of veterinary medicinal products. Harmonisation in this context means unifying requirements across the involved nations to make the authentication process quicker and smoother.

Additional Anthelmintic Guidelines

  • The second objective of this paper was to elaborate on the additional guidelines established by the VICH’s Working Group, focusing on recommendations for the efficacy of anthelmintics, which are drugs used to treat parasitic worm infections, for different animals including horses, pigs, dogs, cats, and poultry.
  • These guidelines, from VICH GL15 to VICH GL21, provide clear but flexible recommendations on the minimum standards required for anthelmintic treatment in each of these animal groups.

Impacts of Harmonisation

  • The harmonisation process provides multiple benefits, primarily to the veterinary profession, livestock producers, and animal owners. It will allow faster access to veterinary anthelmintics that are safer and more effective.
  • This harmonisation process should facilitate more affordability as it would lead to a reduction in registration costs. The newly introduced guidelines also encourage efficient use of resources by regulatory authorities. Therefore, it could also lead to cost savings, making these products more affordable for the end-users.

Cite This Article

APA
Vercruysse J, Holdsworth P, Letonja T, Conder G, Hamamoto K, Okano K, Rehbein S. (2002). International harmonisation of anthelmintic efficacy guidelines (Part 2). Vet Parasitol, 103(4), 277-297. https://doi.org/10.1016/s0304-4017(01)00615-x

Publication

Veterinary parasitology
ISSN: 0304-4017
NlmUniqueID: 7602745
Country: Netherlands
Language: English
Volume: 103
Issue: 4
Pages: 277-297

Researcher Affiliations

Vercruysse, J
  • Faculty of Veterinary Medicine, Department of Parasitology and Parasitic Diseases, Ghent University, Salisburylaan 133, B9820 Merelbeke, Belgium. jozef.vercruysse@rug.ac.be
Holdsworth, P
    Letonja, T
      Conder, G
        Hamamoto, K
          Okano, K
            Rehbein, S

              MeSH Terms

              • Animals
              • Anthelmintics / standards
              • Anthelmintics / therapeutic use
              • Australia
              • Cat Diseases / drug therapy
              • Cat Diseases / parasitology
              • Cats
              • Chickens
              • Dog Diseases / drug therapy
              • Dog Diseases / parasitology
              • Dogs
              • European Union
              • Helminthiasis, Animal / drug therapy
              • Horse Diseases / drug therapy
              • Horse Diseases / parasitology
              • Horses
              • International Cooperation
              • Japan
              • New Zealand
              • Poultry Diseases / drug therapy
              • Poultry Diseases / parasitology
              • Species Specificity
              • Swine
              • Swine Diseases / drug therapy
              • Swine Diseases / parasitology
              • United States
              • Veterinary Drugs / standards
              • Veterinary Drugs / therapeutic use

              Citations

              This article has been cited 27 times.
              1. Mendonça RP, Carneiro DO, Baccin EM, Pirágine MR, Zoca SM, Rossa LAF, Lima GC, Oliveira FB, Costa IS, Oliveira GN, Nogueira SNL, Santos-Doni TRD. Anthelmintic efficacy of oxibendazole against gastrointestinal nematodes in swine. Rev Bras Parasitol Vet 2022;31(1):e018321.
                doi: 10.1590/S1984-29612022009pubmed: 35239858google scholar: lookup
              2. Cutolo AA, Jardina DTG, De Vito GG, Grisi do Nascimento C, Heidmann MJ, Ferreira Nantes JD, Bassetto KV, Chagas IC, Pereira Junior EF, de Castro BG, Tielemans E. Efficacy of two endectoparasiticide products combining fipronil and (S)-methoprene or esafoxolaner with eprinomectin and praziquantel against fleas and intestinal helminths in cats naturally infested in Brazil. Parasite 2022;29:12.
                doi: 10.1051/parasite/2022012pubmed: 35238771google scholar: lookup
              3. Prullage J, Bowman D, Ulrich M, Tielemans E. Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against Echinococcus multilocularis infections in cats. Parasite 2021;28:29.
                doi: 10.1051/parasite/2021025pubmed: 33812461google scholar: lookup
              4. Knaus M, Baker C, Alva R, Mitchell E, Irwin J, Shukullari E, Veliu A, Ibarra-Velarde F, Liebenberg J, Reinemeyer C, Tielemans E, Wakeland K, Johnson C. Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel in cats against Toxocara cati and Dipylidium caninum. Parasite 2021;28:28.
                doi: 10.1051/parasite/2021024pubmed: 33812460google scholar: lookup
              5. Di Cesare A, Morelli S, Morganti G, Simonato G, Veronesi F, Colombo M, Berlanda M, Lebon W, Gallo M, Beugnet F, Traversa D. Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA(®)) against Capillaria aerophila and Capillaria boehmi in naturally infected dogs. Parasit Vectors 2021 Mar 6;14(1):143.
                doi: 10.1186/s13071-021-04648-ypubmed: 33676579google scholar: lookup
              6. Knaus M, Visser M, Mayr S, Rehbein S. Efficacy of a topical combination of eprinomectin, praziquantel, fipronil and (S)-methoprene against developing and adult Troglostrongylus brevior lungworms (Nematoda, Crenosomatidae) in cats. Vet Parasitol X 2020 Dec;4:100032.
                doi: 10.1016/j.vpoa.2020.100032pubmed: 33083781google scholar: lookup
              7. Knaus M, Taweethavonsawat P, Cheesman T, Visser M, Rehbein S. Efficacy of Broadline® in cats against induced infections with developing fourth-stage larval and adult Ancylostoma ceylanicum hookworms. Vet Parasitol X 2020 May;3:100025.
                doi: 10.1016/j.vpoa.2020.100025pubmed: 32904740google scholar: lookup
              8. Becskei C, Kryda K, Thys M, Holzmer S, Bowersock L, Fernandes T, Meyer L, Reinemeyer C, Mahabir SP. Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced ascarid infections in dogs. Parasit Vectors 2020 Mar 1;13(1):71.
                doi: 10.1186/s13071-020-3950-5pubmed: 32113482google scholar: lookup
              9. Becskei C, Thys M, Kryda K, Meyer L, Martorell S, Geurden T, Dreesen L, Fernandes T, Mahabir SP. Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs. Parasit Vectors 2020 Mar 1;13(1):99.
                doi: 10.1186/s13071-020-3951-4pubmed: 32113471google scholar: lookup
              10. Maestrini M, Tava A, Mancini S, Salari F, Perrucci S. In Vitro Anthelmintic Activity of Saponins Derived from Medicago spp. Plants against Donkey Gastrointestinal Nematodes. Vet Sci 2019 Mar 29;6(2).
                doi: 10.3390/vetsci6020035pubmed: 30934808google scholar: lookup
              11. Lebon W, Guillot J, Álvarez MJ, Antonio Bazaga J, Cortes-Dubly ML, Dumont P, Eberhardt M, Gómez H, Pennant O, Siméon N, Beugnet F, Halos L. Prevention of canine ocular thelaziosis (Thelazia callipaeda) with a combination of milbemycin oxime and afoxolaner (Nexgard Spectra(®)) in endemic areas in France and Spain. Parasite 2019;26:1.
                doi: 10.1051/parasite/2019001pubmed: 30644355google scholar: lookup
              12. Wang T, Xie Y, Zheng Y, Wang C, Li D, Koehler AV, Gasser RB. Parasites of the Giant Panda: A Risk Factor in the Conservation of a Species. Adv Parasitol 2018;99:1-33.
                doi: 10.1016/bs.apar.2017.12.003pubmed: 29530307google scholar: lookup
              13. Vidyashankar AN, Jimenez Castro PD, Kaplan RM. A statistical approach for evaluating the effectiveness of heartworm preventive drugs: what does 100% efficacy really mean?. Parasit Vectors 2017 Nov 9;10(Suppl 2):516.
                doi: 10.1186/s13071-017-2440-xpubmed: 29143648google scholar: lookup
              14. Genchi M, Geneteau A, Forget P, Delcombel R, Genchi C. Pharmacokinetics and efficacy of an ivermectin implant for long-term prevention of Dirofilaria immitis infection in dogs. Parasitol Res 2017 Jun;116(6):1723-1728.
                doi: 10.1007/s00436-017-5448-4pubmed: 28432479google scholar: lookup
              15. Rehbein S, Knaus M, Mallouk Y, Breiltgens T, Brianti E, Capári B, Dantas-Torres F, Gau M, Joachim A, Kaulfuß KH, Kirkova Z, Lechner J, Mihalca AD, Mirabito R, Petkevičius S, Rapti D, Shukullari E, Sedeilhan M, Dollhofer D, Kley K, Lebon W, Visser M, Jeannin P. Efficacy against nematode infections and safety of afoxolaner plus milbemycin oxime chewable tablets in domestic dogs under field conditions in Europe. Parasitol Res 2017 Jan;116(1):259-269.
                doi: 10.1007/s00436-016-5287-8pubmed: 27771803google scholar: lookup
              16. Lebon W, Tielemans E, Rehbein S, Dumont P, Yoon S, Beugnet F, Jeannin P, Larsen D, Halos L. Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs. Parasit Vectors 2016 Sep 2;9(1):485.
                doi: 10.1186/s13071-016-1773-1pubmed: 27589951google scholar: lookup
              17. Schuster RK, Mustafa MB, Baskar JV, Rosentel J, Chester ST, Knaus M. Efficacy of a topical combination of fipronil, (S)-methoprene, eprinomectin and praziquantel (Broadline(®)) against naturally acquired infections with cestodes of the genus Joyeuxiella in cats. Parasitol Res 2016 Jul;115(7):2679-84.
                doi: 10.1007/s00436-016-5016-3pubmed: 27026504google scholar: lookup
              18. Knaus M, Shukullari E, Rapti D, Rehbein S. Efficacy of Broadline against Capillaria aerophila lungworm infection in cats. Parasitol Res 2015 May;114(5):1971-5.
                doi: 10.1007/s00436-015-4386-2pubmed: 25681144google scholar: lookup
              19. Vilela VL, Feitosa TF, Braga FR, de Araújo JV, de Lucena SC, Dantas ES, Athayde AC, Silva WW. Efficacy of Monacrosporium thaumasium in the control of goat gastrointestinal helminthiasis in a semi-arid region of Brazil. Parasitol Res 2013 Feb;112(2):871-7.
                doi: 10.1007/s00436-012-3078-4pubmed: 22903419google scholar: lookup
              20. Humak F, Buono F, Veneziano V, Piantedosi D, Castaldo E, Scarcelli S, Locantore F, Rivolta AP, Rotondi S, Mencke N, Blazejak K. Field efficacy of Febantel, Pyrantel embonate and Praziquantel (Drontal® Tasty) against naturally acquired intestinal helminths of hunting dogs in southern Italy. Parasit Vectors 2025 Sep 24;18(1):377.
                doi: 10.1186/s13071-025-07027-zpubmed: 40993797google scholar: lookup
              21. Charles S, Wiseman S, Wang X, Savadelis MD, Reinemeyer CR, Bouzaidi Cheikhi I, Rautenbach C, Young L. Efficacy of a novel chewable tablet (Credelio Quattro(™)) containing lotilaner, moxidectin, praziquantel, and pyrantel against Toxocara canis and Toxascaris leonina infections in dogs. Parasit Vectors 2025 Aug 20;18(1):356.
                doi: 10.1186/s13071-025-06968-9pubmed: 40836259google scholar: lookup
              22. Charles S, Wiseman S, Savadelis MD, Nichols E, Young L. Field efficacy and safety evaluation of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel against gastrointestinal nematode infections in dogs in the USA. Parasit Vectors 2025 Jul 25;18(1):297.
                doi: 10.1186/s13071-025-06932-7pubmed: 40713857google scholar: lookup
              23. Packianathan R, Hodge A, Bruellke N, Pearce M, Selepe F, Taweethavonsawat P, Geurden T. Efficacy of Simparica Trio® against induced infections of Ancylostoma braziliense and Ancylostoma ceylanicum in dogs. Parasit Vectors 2025 Apr 28;18(1):159.
                doi: 10.1186/s13071-025-06758-3pubmed: 40296062google scholar: lookup
              24. Charles S, Deuster K, Wang X, Wiseman S, Reinemeyer CR, van der Mescht L, Mansour A, Bouzaidi Cheikhi I, Young L. Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs. Parasit Vectors 2025 Apr 2;18(1):125.
                doi: 10.1186/s13071-025-06757-4pubmed: 40176170google scholar: lookup
              25. Charles S, Altreuther G, Wang X, Wiseman S, Reinemeyer CR, Snyder DE, Ulrich M, Doherty P, Young L. Efficacy of a novel chewable tablet (Credelio Quattro(™)) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs. Parasit Vectors 2025 Mar 11;18(1):99.
                doi: 10.1186/s13071-025-06735-wpubmed: 40065412google scholar: lookup
              26. Raw C, Traub RJ, Wiethoelter A. A comparative field efficacy trial of three treatment programs against endo- and ectoparasites in naturally infected dogs. Front Vet Sci 2024;11:1460452.
                doi: 10.3389/fvets.2024.1460452pubmed: 39301281google scholar: lookup
              27. Martin EM, Mitchell EB, Yoon S, McCall JW, Fankhauser B, Mansour A, McCall S, Pollmeier M. Efficacy of moxidectin, using various dose regimens, against JYD-34, a macrocyclic lactone resistant isolate of Dirofilaria immitis. Parasit Vectors 2024 Apr 4;17(1):176.
                doi: 10.1186/s13071-024-06149-0pubmed: 38575969google scholar: lookup
              Subscribe to our newsletter
              Join 99,727 horse owners like you who receive our email updates on horse health and nutrition.